Pease Flavia
SEC CIK 1924996 · EDGAR
Most active insiders at PODD, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| 1 | McEvoy Ashley | Pres, CEO, Dir | $1.19M | — |
| 2 | STONESIFER TIMOTHY C. | Dir | $700.3K | — |
| 3 | Frederick Wayne A.I. | Dir | — | $542.5K |
| 4 | MINOGUE MICHAEL R | Dir | $499.8K | — |
| 5 | WEATHERMAN ELIZABETH H | Dir | $497.5K | — |
| 6 | BORIO LUCIANA | Dir | — | $59.9K |
| 7 | Panos Michael | EVP, CCO | — | — |
| 8 | Davis Lisa Blair | SVP, Chief HR Off | — | — |
| 9 | Singh Prem | SVP, Gbl Ops | — | — |
| 10 | Cousin Laetitia | SVP, Reg, Quality, Compliance | — | — |
| 11 | Pease Flavia | EVP, CFO | — | — |
Transactions 19
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2026-02-26 | 2026-02-24 | PODD | Insulet Corporation | Pease Flavia | EVP, CFO | A - Grant | $0.00 | +3,822 | 19.2K | +25% | $0 |
| D | 2025-10-02 | 2025-10-01 | PODD | Insulet Corporation | Pease Flavia | EVP, CFO | A - Grant | $0.00 | +11.7K | 15.3K | +323% | $0 |
| 2025-06-03 | 2025-05-30 | CRL | Charles River Laboratories | Pease Flavia | CFO, Corp. Executive VP | A - Grant | $135.63 | +7,152 | 17.5K | +69% | +$970.0K | |
| 2025-06-03 | 2025-05-31 | CRL | Charles River Laboratories | Pease Flavia | CFO, Corp. Executive VP | F - Tax | $135.63 | -185 | 17.3K | -1% | -$25.1K | |
| M | 2025-05-29 | 2025-05-26+ | CRL | Charles River Laboratories | Pease Flavia | CFO, Corp. Executive VP | F - Tax | $136.73 | -331 | 10.3K | -3% | -$45.3K |
| 2025-05-27 | 2025-05-22 | PODD | Insulet Corporation | Pease Flavia | Dir | A - Grant | $0.00 | +778 | 3,629 | +27% | $0 | |
| 2025-05-05 | 2025-05-02 | CRL | Charles River Laboratories | Pease Flavia | CFO, Corp. Executive VP | F - Tax | $116.89 | -889 | 10.7K | -8% | -$103.9K | |
| 2025-02-03 | 2025-01-31 | CRL | Charles River Laboratories | Pease Flavia | CFO, Corp. Executive VP | A - Grant | $0.00 | +2,704 | 12.5K | +28% | $0 | |
| 2025-02-03 | 2025-01-31 | CRL | Charles River Laboratories | Pease Flavia | CFO, Corp. Executive VP | F - Tax | $165.57 | -914 | 11.6K | -7% | -$151.3K | |
| D | 2024-06-04 | 2024-05-31 | CRL | Charles River Laboratories | Pease Flavia | CFO, Corp. Executive VP | A - Grant | $0.00 | +2,159 | 9,760 | +28% | $0 |
| MA | 2024-05-30 | 2024-05-26+ | CRL | Charles River Laboratories | Pease Flavia | CFO, Corp. Executive VP | F - Tax | $217.21 | -406 | 7,795 | -5% | -$88.2K |
| M | 2024-05-29 | 2024-05-26+ | CRL | Charles River Laboratories | Pease Flavia | CFO, Corp. Executive VP | F - Tax | $217.21 | -356 | 7,651 | -4% | -$77.3K |
| 2024-05-23 | 2024-05-22 | PODD | Insulet Corporation | Pease Flavia | Dir | A - Grant | $0.00 | +1,380 | 2,851 | +94% | $0 | |
| 2024-05-03 | 2024-05-02 | CRL | Charles River Laboratories | Pease Flavia | CFO, Corp. Executive VP | F - Tax | $232.69 | -893 | 8,007 | -10% | -$207.8K | |
| 2024-01-22 | 2024-01-18 | PODD | Insulet Corporation | Pease Flavia | Dir | A - Grant | $0.00 | +1,471 | 1,471 | New | $0 | |
| D | 2023-05-31 | 2023-05-27 | CRL | Charles River Laboratories | Pease Flavia | CFO, Corp. Executive VP | F - Tax | $194.12 | -137 | 8,900 | -2% | -$26.6K |
| D | 2023-05-31 | 2023-05-26 | CRL | Charles River Laboratories | Pease Flavia | CFO, Corp. Executive VP | A - Grant | $0.00 | +2,215 | 9,037 | +32% | $0 |
| D | 2022-06-01 | 2022-05-27 | CRL | Charles River Laboratories | Pease Flavia | CFO, Corp. Executive VP | A - Grant | $0.00 | +1,637 | 6,822 | +32% | $0 |
| D | 2022-05-04 | 2022-05-02 | CRL | Charles River Laboratories | Pease Flavia | Corp. Executive VP | A - Grant | $0.00 | +5,185 | 5,185 | New | $0 |
Purchase Sale Sale after option exercise All abbreviations